Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
37
CLOV Quote, Financials, Valuation and Earnings
Last price:
$2.54
Seasonality move
:
-10.34%
Day range:
$2.51 - $2.59
52-week range:
$2.12 - $4.87
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.72x
P/B ratio:
3.83x
Volume:
3.5M
Avg. volume:
4.7M
1-year change:
-22.94%
Market cap:
$1.3B
Revenue:
$1.4B
EPS (TTM):
-$0.12
Price Performance History
Performance vs. Valuation Benchmarks
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Competitors
| Company | Revenue Forecast | Earnings Forecast | Revenue Growth Forecast | Earnings Growth Forecast | Analyst Price Target Median |
|---|---|---|---|---|---|
|
CLOV
Clover Health Investments Corp.
|
$471.1M | $0.02 | 38.62% | -11.36% | $3.23 |
|
ALHC
Alignment Healthcare, Inc.
|
$981.4M | -$0.01 | 43.14% | -50.62% | $21.46 |
|
CI
The Cigna Group
|
$66.7B | $7.64 | 5.44% | 53.57% | $324.92 |
|
NEUE
NeueHealth, Inc.
|
$256.8M | -$3.65 | -10.61% | -86.91% | $7.00 |
|
OSCR
Oscar Health, Inc.
|
$3.1B | -$0.58 | 30.55% | -48.95% | $14.67 |
|
PGNY
Progyny, Inc.
|
$299.2M | $0.39 | 2.56% | 231.72% | $29.40 |
| Company | Price | Analyst Target | Market Cap | P/E Ratio | Dividend per Share | Dividend Yield | Price / LTM Sales |
|---|---|---|---|---|---|---|---|
|
CLOV
Clover Health Investments Corp.
|
$2.53 | $3.23 | $1.3B | -- | $0.00 | 0% | 0.72x |
|
ALHC
Alignment Healthcare, Inc.
|
$19.52 | $21.46 | $3.9B | -- | $0.00 | 0% | 1.08x |
|
CI
The Cigna Group
|
$273.78 | $324.92 | $73.1B | 12.08x | $1.51 | 2.21% | 0.28x |
|
NEUE
NeueHealth, Inc.
|
$6.75 | $7.00 | $60.9M | -- | $0.00 | 0% | 0.06x |
|
OSCR
Oscar Health, Inc.
|
$14.84 | $14.67 | $4.3B | 51.21x | $0.00 | 0% | 0.35x |
|
PGNY
Progyny, Inc.
|
$25.57 | $29.40 | $2.2B | 40.48x | $0.00 | 0% | 1.80x |
| Company | Total Debt / Total Capital | Beta | Debt to Equity | Quick Ratio |
|---|---|---|---|---|
|
CLOV
Clover Health Investments Corp.
|
-- | 1.600 | -- | 0.00x |
|
ALHC
Alignment Healthcare, Inc.
|
67.07% | -0.951 | 9.45% | 0.00x |
|
CI
The Cigna Group
|
44.88% | -0.464 | 44.1% | 0.00x |
|
NEUE
NeueHealth, Inc.
|
-90.69% | -0.960 | 20.55% | 0.00x |
|
OSCR
Oscar Health, Inc.
|
40.13% | 3.840 | 13.86% | 0.00x |
|
PGNY
Progyny, Inc.
|
4.79% | -0.543 | 1.52% | 3.10x |
| Company | Gross Profit | Operating Income | Return on Invested Capital | Return on Common Equity | EBIT Margin | Free Cash Flow |
|---|---|---|---|---|---|---|
|
CLOV
Clover Health Investments Corp.
|
-- | -$24.4M | -16.89% | -16.93% | -4.91% | $11.4M |
|
ALHC
Alignment Healthcare, Inc.
|
-- | $7.7M | -4.83% | -16.74% | 0.38% | $139.1M |
|
CI
The Cigna Group
|
-- | $2.6B | 8.94% | 15.87% | 3.29% | $3.1B |
|
NEUE
NeueHealth, Inc.
|
-- | $14.3M | -1375.06% | -3241.93% | 3.26% | -$4.5M |
|
OSCR
Oscar Health, Inc.
|
-- | -$129.3M | -16.06% | -21.36% | -4.67% | -$973.7M |
|
PGNY
Progyny, Inc.
|
$72.8M | $21.5M | 11.21% | 11.79% | 6.87% | $46M |
Clover Health Investments Corp. vs. Competitors
-
Which has Higher Returns CLOV or ALHC?
Alignment Healthcare, Inc. has a net margin of -4.91% compared to Clover Health Investments Corp.'s net margin of 0.38%. Clover Health Investments Corp.'s return on equity of -16.93% beat Alignment Healthcare, Inc.'s return on equity of -16.74%.
Company Gross Margin Earnings Per Share Invested Capital CLOVClover Health Investments Corp.-- -$0.05 $340.9M ALHCAlignment Healthcare, Inc.-- $0.02 $491.5M -
What do Analysts Say About CLOV or ALHC?
Clover Health Investments Corp. has a consensus price target of $3.23, signalling upside risk potential of 24.36%. On the other hand Alignment Healthcare, Inc. has an analysts' consensus of $21.46 which suggests that it could grow by 6.28%. Given that Clover Health Investments Corp. has higher upside potential than Alignment Healthcare, Inc., analysts believe Clover Health Investments Corp. is more attractive than Alignment Healthcare, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CLOVClover Health Investments Corp.1 2 0 ALHCAlignment Healthcare, Inc.9 2 0 -
Is CLOV or ALHC More Risky?
Clover Health Investments Corp. has a beta of 2.243, which suggesting that the stock is 124.341% more volatile than S&P 500. In comparison Alignment Healthcare, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CLOV or ALHC?
Clover Health Investments Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Alignment Healthcare, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments Corp. pays -- of its earnings as a dividend. Alignment Healthcare, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CLOV or ALHC?
Clover Health Investments Corp. quarterly revenues are $496.7M, which are smaller than Alignment Healthcare, Inc. quarterly revenues of $993.7M. Clover Health Investments Corp.'s net income of -$24.4M is lower than Alignment Healthcare, Inc.'s net income of $3.7M. Notably, Clover Health Investments Corp.'s price-to-earnings ratio is -- while Alignment Healthcare, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments Corp. is 0.72x versus 1.08x for Alignment Healthcare, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLOVClover Health Investments Corp.0.72x -- $496.7M -$24.4M ALHCAlignment Healthcare, Inc.1.08x -- $993.7M $3.7M
-
Which has Higher Returns CLOV or CI?
The Cigna Group has a net margin of -4.91% compared to Clover Health Investments Corp.'s net margin of 2.83%. Clover Health Investments Corp.'s return on equity of -16.93% beat The Cigna Group's return on equity of 15.87%.
Company Gross Margin Earnings Per Share Invested Capital CLOVClover Health Investments Corp.-- -$0.05 $340.9M CIThe Cigna Group-- $6.98 $76.1B -
What do Analysts Say About CLOV or CI?
Clover Health Investments Corp. has a consensus price target of $3.23, signalling upside risk potential of 24.36%. On the other hand The Cigna Group has an analysts' consensus of $324.92 which suggests that it could grow by 17.9%. Given that Clover Health Investments Corp. has higher upside potential than The Cigna Group, analysts believe Clover Health Investments Corp. is more attractive than The Cigna Group.
Company Buy Ratings Hold Ratings Sell Ratings CLOVClover Health Investments Corp.1 2 0 CIThe Cigna Group15 4 0 -
Is CLOV or CI More Risky?
Clover Health Investments Corp. has a beta of 2.243, which suggesting that the stock is 124.341% more volatile than S&P 500. In comparison The Cigna Group has a beta of 0.257, suggesting its less volatile than the S&P 500 by 74.285%.
-
Which is a Better Dividend Stock CLOV or CI?
Clover Health Investments Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. The Cigna Group offers a yield of 2.21% to investors and pays a quarterly dividend of $1.51 per share. Clover Health Investments Corp. pays -- of its earnings as a dividend. The Cigna Group pays out 46.19% of its earnings as a dividend. The Cigna Group's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.
-
Which has Better Financial Ratios CLOV or CI?
Clover Health Investments Corp. quarterly revenues are $496.7M, which are smaller than The Cigna Group quarterly revenues of $69.8B. Clover Health Investments Corp.'s net income of -$24.4M is lower than The Cigna Group's net income of $2B. Notably, Clover Health Investments Corp.'s price-to-earnings ratio is -- while The Cigna Group's PE ratio is 12.08x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments Corp. is 0.72x versus 0.28x for The Cigna Group. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLOVClover Health Investments Corp.0.72x -- $496.7M -$24.4M CIThe Cigna Group0.28x 12.08x $69.8B $2B
-
Which has Higher Returns CLOV or NEUE?
NeueHealth, Inc. has a net margin of -4.91% compared to Clover Health Investments Corp.'s net margin of 3.27%. Clover Health Investments Corp.'s return on equity of -16.93% beat NeueHealth, Inc.'s return on equity of -3241.93%.
Company Gross Margin Earnings Per Share Invested Capital CLOVClover Health Investments Corp.-- -$0.05 $340.9M NEUENeueHealth, Inc.-- -$2.62 -$179.6M -
What do Analysts Say About CLOV or NEUE?
Clover Health Investments Corp. has a consensus price target of $3.23, signalling upside risk potential of 24.36%. On the other hand NeueHealth, Inc. has an analysts' consensus of $7.00 which suggests that it could grow by 3.66%. Given that Clover Health Investments Corp. has higher upside potential than NeueHealth, Inc., analysts believe Clover Health Investments Corp. is more attractive than NeueHealth, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CLOVClover Health Investments Corp.1 2 0 NEUENeueHealth, Inc.0 0 0 -
Is CLOV or NEUE More Risky?
Clover Health Investments Corp. has a beta of 2.243, which suggesting that the stock is 124.341% more volatile than S&P 500. In comparison NeueHealth, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CLOV or NEUE?
Clover Health Investments Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. NeueHealth, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments Corp. pays -- of its earnings as a dividend. NeueHealth, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CLOV or NEUE?
Clover Health Investments Corp. quarterly revenues are $496.7M, which are larger than NeueHealth, Inc. quarterly revenues of $209.1M. Clover Health Investments Corp.'s net income of -$24.4M is lower than NeueHealth, Inc.'s net income of $6.8M. Notably, Clover Health Investments Corp.'s price-to-earnings ratio is -- while NeueHealth, Inc.'s PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments Corp. is 0.72x versus 0.06x for NeueHealth, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLOVClover Health Investments Corp.0.72x -- $496.7M -$24.4M NEUENeueHealth, Inc.0.06x -- $209.1M $6.8M
-
Which has Higher Returns CLOV or OSCR?
Oscar Health, Inc. has a net margin of -4.91% compared to Clover Health Investments Corp.'s net margin of -4.6%. Clover Health Investments Corp.'s return on equity of -16.93% beat Oscar Health, Inc.'s return on equity of -21.36%.
Company Gross Margin Earnings Per Share Invested Capital CLOVClover Health Investments Corp.-- -$0.05 $340.9M OSCROscar Health, Inc.-- -$0.53 $1.7B -
What do Analysts Say About CLOV or OSCR?
Clover Health Investments Corp. has a consensus price target of $3.23, signalling upside risk potential of 24.36%. On the other hand Oscar Health, Inc. has an analysts' consensus of $14.67 which suggests that it could fall by -1.17%. Given that Clover Health Investments Corp. has higher upside potential than Oscar Health, Inc., analysts believe Clover Health Investments Corp. is more attractive than Oscar Health, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CLOVClover Health Investments Corp.1 2 0 OSCROscar Health, Inc.0 4 3 -
Is CLOV or OSCR More Risky?
Clover Health Investments Corp. has a beta of 2.243, which suggesting that the stock is 124.341% more volatile than S&P 500. In comparison Oscar Health, Inc. has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.
-
Which is a Better Dividend Stock CLOV or OSCR?
Clover Health Investments Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Oscar Health, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments Corp. pays -- of its earnings as a dividend. Oscar Health, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CLOV or OSCR?
Clover Health Investments Corp. quarterly revenues are $496.7M, which are smaller than Oscar Health, Inc. quarterly revenues of $3B. Clover Health Investments Corp.'s net income of -$24.4M is higher than Oscar Health, Inc.'s net income of -$137.5M. Notably, Clover Health Investments Corp.'s price-to-earnings ratio is -- while Oscar Health, Inc.'s PE ratio is 51.21x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments Corp. is 0.72x versus 0.35x for Oscar Health, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLOVClover Health Investments Corp.0.72x -- $496.7M -$24.4M OSCROscar Health, Inc.0.35x 51.21x $3B -$137.5M
-
Which has Higher Returns CLOV or PGNY?
Progyny, Inc. has a net margin of -4.91% compared to Clover Health Investments Corp.'s net margin of 4.43%. Clover Health Investments Corp.'s return on equity of -16.93% beat Progyny, Inc.'s return on equity of 11.79%.
Company Gross Margin Earnings Per Share Invested Capital CLOVClover Health Investments Corp.-- -$0.05 $340.9M PGNYProgyny, Inc.23.24% $0.15 $588.2M -
What do Analysts Say About CLOV or PGNY?
Clover Health Investments Corp. has a consensus price target of $3.23, signalling upside risk potential of 24.36%. On the other hand Progyny, Inc. has an analysts' consensus of $29.40 which suggests that it could grow by 14.98%. Given that Clover Health Investments Corp. has higher upside potential than Progyny, Inc., analysts believe Clover Health Investments Corp. is more attractive than Progyny, Inc..
Company Buy Ratings Hold Ratings Sell Ratings CLOVClover Health Investments Corp.1 2 0 PGNYProgyny, Inc.6 4 0 -
Is CLOV or PGNY More Risky?
Clover Health Investments Corp. has a beta of 2.243, which suggesting that the stock is 124.341% more volatile than S&P 500. In comparison Progyny, Inc. has a beta of 0.969, suggesting its less volatile than the S&P 500 by 3.145%.
-
Which is a Better Dividend Stock CLOV or PGNY?
Clover Health Investments Corp. has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Progyny, Inc. offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Clover Health Investments Corp. pays -- of its earnings as a dividend. Progyny, Inc. pays out -- of its earnings as a dividend.
-
Which has Better Financial Ratios CLOV or PGNY?
Clover Health Investments Corp. quarterly revenues are $496.7M, which are larger than Progyny, Inc. quarterly revenues of $313.3M. Clover Health Investments Corp.'s net income of -$24.4M is lower than Progyny, Inc.'s net income of $13.9M. Notably, Clover Health Investments Corp.'s price-to-earnings ratio is -- while Progyny, Inc.'s PE ratio is 40.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Clover Health Investments Corp. is 0.72x versus 1.80x for Progyny, Inc.. Usually stocks with elevated PS ratios are considered overvalued.
Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income CLOVClover Health Investments Corp.0.72x -- $496.7M -$24.4M PGNYProgyny, Inc.1.80x 40.48x $313.3M $13.9M
Related Companies
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
59
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
53
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 36x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
60
AAOI alert for Dec 24
Applied Optoelectronics, Inc. [AAOI] is up 5.1% over the past day.
Buy
85
HUT alert for Dec 24
Hut 8 Corp. [HUT] is up 0.65% over the past day.
Buy
63
GPCR alert for Dec 24
Structure Therapeutics, Inc. [GPCR] is down 2.36% over the past day.
